JP2024517658A5 - - Google Patents
Info
- Publication number
- JP2024517658A5 JP2024517658A5 JP2023564434A JP2023564434A JP2024517658A5 JP 2024517658 A5 JP2024517658 A5 JP 2024517658A5 JP 2023564434 A JP2023564434 A JP 2023564434A JP 2023564434 A JP2023564434 A JP 2023564434A JP 2024517658 A5 JP2024517658 A5 JP 2024517658A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- mhc class
- amino acid
- acid substitution
- tmp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163177641P | 2021-04-21 | 2021-04-21 | |
| US63/177,641 | 2021-04-21 | ||
| PCT/US2022/025547 WO2022226069A1 (en) | 2021-04-21 | 2022-04-20 | Mhc class ii t-cell modulatory polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517658A JP2024517658A (ja) | 2024-04-23 |
| JP2024517658A5 true JP2024517658A5 (enExample) | 2025-04-28 |
Family
ID=83723127
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564434A Pending JP2024517658A (ja) | 2021-04-21 | 2022-04-20 | １型真性糖尿病（ｔ１ｄ）を治療するためのｍｈｃクラスｉｉ ｔ細胞調節ポリペプチド及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240101627A1 (enExample) |
| EP (1) | EP4326754A4 (enExample) |
| JP (1) | JP2024517658A (enExample) |
| CN (1) | CN117337298A (enExample) |
| AU (1) | AU2022261908A1 (enExample) |
| CA (1) | CA3212762A1 (enExample) |
| WO (1) | WO2022226069A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020534352A (ja) | 2017-09-07 | 2020-11-26 | キュー バイオファーマ，インコーポレーテッド | コンジュゲーション部位を有するｔ細胞調節多量体ポリペプチド及びその使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107709356A (zh) * | 2015-06-26 | 2018-02-16 | 南加利福尼亚大学 | 用于肿瘤特异性活化的掩蔽嵌合抗原受体t细胞 |
| US20200231652A1 (en) * | 2015-08-31 | 2020-07-23 | National Research Council Of Canada | Tgf-b-receptor ectodomain fusion molecules and uses thereof |
| WO2020132366A2 (en) * | 2018-12-19 | 2020-06-25 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof |
| WO2020132365A2 (en) * | 2018-12-19 | 2020-06-25 | Cue Biopharma, Inc. | T-cell modulatory multimeric polypeptides with conjugation sites and methods of use thereof |
| EP3897690A4 (en) * | 2018-12-19 | 2022-09-28 | Cue Biopharma, Inc. | T LYMPHOCYTE MODULATOR MULTIMERIC POLYPEPTIDES HAVING CONJUGATION SITES AND METHODS OF USE THEREOF |
| JP2022522405A (ja) * | 2019-03-06 | 2022-04-19 | キュー バイオファーマ， インコーポレイテッド | Ｔ細胞調節多量体ポリペプチド及びその使用方法 |
| EP3935079A4 (en) * | 2019-03-06 | 2023-03-22 | Cue Biopharma, Inc. | T-CELL MODULATING ANTIGEN PRESENT POLYPEPTIDES AND METHODS OF USE THEREOF |
| WO2022226058A1 (en) * | 2021-04-22 | 2022-10-27 | Cue Biopharma, Inc. | Antigen-presenting polypeptides with chemical conjugation sites and methods of use thereof |
-
2022
- 2022-04-20 AU AU2022261908A patent/AU2022261908A1/en active Pending
- 2022-04-20 JP JP2023564434A patent/JP2024517658A/ja active Pending
- 2022-04-20 EP EP22792411.5A patent/EP4326754A4/en active Pending
- 2022-04-20 CN CN202280035858.4A patent/CN117337298A/zh active Pending
- 2022-04-20 CA CA3212762A patent/CA3212762A1/en active Pending
- 2022-04-20 WO PCT/US2022/025547 patent/WO2022226069A1/en not_active Ceased
-
2023
- 2023-10-02 US US18/375,848 patent/US20240101627A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100484084B1 (ko) | 키메라성 폴리펩타이드, 이의 제조 방법 및 용도 | |
| JP2022534846A5 (enExample) | ||
| Ikuta et al. | Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. | |
| Fujii et al. | A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. | |
| JP2021191265A5 (enExample) | ||
| JP3280376B2 (ja) | 多価抗原結合性蛋白質 | |
| JP2023527049A5 (enExample) | ||
| GB2611448A (en) | Polypeptide useful in adoptive cell therapy | |
| JP2021500855A5 (enExample) | ||
| CN117986384A (zh) | 与il-12和il-18的基于il-15的融合物 | |
| BR112020000769A2 (pt) | anticorpo de dupla especificidade, moléculas polipeptídicas, ácido nucleico, célula hospedeira, composição farmacêutica e método de tratamento de uma doença ou condição | |
| JP2022515330A5 (enExample) | ||
| JP2024512470A5 (enExample) | ||
| JP2023526723A5 (enExample) | ||
| JPS61257998A (ja) | ヘテロダイマ性ｔリンパ球レセプタ | |
| JP2023541366A5 (enExample) | ||
| JP2022522404A (ja) | Ｔ細胞調節抗原提示ポリペプチド及びその使用方法 | |
| Leiden et al. | The complete primary structure of the T-cell receptor genes from an alloreactive cytotoxic human T-lymphocyte clone | |
| LV11630B (en) | T cell antigen receptor v region proteins and methods of preparation thereof | |
| CN111892661A (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| JP7742354B2 (ja) | Ｇ１２ｖ変異を有するｒａｓに対するｈｌａクラスｉｉ拘束性ｔ細胞受容体 | |
| JP2023530182A5 (enExample) | ||
| US20240190933A1 (en) | Antigen Presenting Polypeptide Complexes Bearing TGF-Beta and Methods of Use Thereof | |
| JP2024517658A5 (enExample) | ||
| JP2022523024A5 (enExample) |